BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement With VITARRAY Global Pte. Ltd. Focusing On The Provision Of MRNA Dynamic Gene Detection Services For The Southeast Asian Market
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement With VITARRAY Global Pte. Ltd. Focusing On The Provision Of MRNA Dynamic Gene Detection Services For The Southeast Asian Market
BioNexus Gene Lab Corp. (NASDAQ:BGLC, the "Company"))))), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce that its wholly owned subsidiary, MRNA Scientific Sdn. Bhd. ("MRNA Scientific"), has entered into a strategic outsourcing agreement with VITARRAY Global Pte. Ltd. ("Vitarray"), an exempted private company incorporated in Singapore. This agreement focuses on the provision of mRNA dynamic gene detection services for the Southeast Asian market.
BioNexus Gene Lab corp（纳斯达克：BGLC，"公司"）是一家新兴的生物技术公司，专注于创新的医疗解决方案。该公司很高兴地宣布，其全资子公司MRNA Scientific私人有限责任公司（"MRNA Scientific"）已与全球货币VITARRAY私人有限责任公司（"Vitarray"）签订战略外包协议。该协议重点关注为东南亚市场提供mRNA动态基因检测服务。
Under this agreement, MRNA Scientific will leverage its advanced medical testing facilities located in Kuala Lumpur, Malaysia, to provide outsourcing services for Vitarray's mRNA gene detection activities. This collaboration is aimed at enhancing the deployment of advanced molecular diagnostics throughout Southeast Asia, facilitating early disease detection and expanding access to innovative healthcare technologies.
根据该协议，MRNA Scientific将利用其位于马来西亚吉隆坡的先进医疗测试设施，为Vitarray的mRNA基因检测活动提供外包服务。此次合作旨在加强在东南亚地区的先进分子诊断的应用，促进早期疾病检测，并扩大对创新医疗技术的获取。